Novavax-2-vaccine-stocks-that-can-double-your-money-part2

  Novavax - 2 Vaccine Stocks That Can Double Your Money - Part2 In our previous content, we stated that it was not late to invest in vaccine stocks, which soared last year, and we examined one of the leading companies, Moderna, in detail. In this content, we will discuss the other potential promising vaccine company Novavax.  

2-Novavax

  You may be skeptical when I say that Novavax still has climbing potential. This is because the shares increased by 2,700 % last year. However, this increase was before Novavax announced its Phase 3 experimental results and its plan to address alarming challenges. These elements and Novavax's huge production network show that it is on its way to getting the coronavirus vaccine giant at the clinical stage. Novavax's phase 3 study in the UK showed that the vaccine was 96 % effective against the original coronavirus. This result surpasses Pfizer with Moderna, which appears to be the leader in the market and was reported to be 94,1 % and 95 % effective, respectively. In the UK, Novavax showed 86,3 % effectiveness against mutation. The 2b trial showed that the vaccine was 55,4 % effective against the South African mutation. The trial took place in South Africa, where the variant accounts for 90 % of coronavirus cases. These results are strong, but Novavax takes things a step further. Novavax, like Moderna, is working on a new vaccine to target emerging strains and plans to complete its work by the middle of the year. If Novavax develops a new vaccine against mutation, it is also capable of mass-producing it. Novavax plans to produce 2 billion doses of vaccine as of the middle of the year, while Moderna's target is between 700 million and 1 billion doses this year.

When can we expect it to come? When will the return be?

  Strategists expect a return this summer. Novavax will report data from the US phase 3 study in the coming weeks. And the company expects to complete the EUA request in the second quarter. If the FDA likes what it sees, the Novavax vaccine may hit the market a few weeks after filing. Considering the profit potential, Novavax's shares are not expensive. Slightly more than six times the future earnings estimates are being traded.  

When will these stocks double your money?

  First of all, keep in mind that this may not happen. If the FDA does not authorize Novavax's candidate and Moderna's strain-specific support program fails, both stocks will collapse. It should be noted that both stocks are extremely dependent on companies' coronavirus vaccine programs.  

Source: The Motley Fool

 

You may also be interrested in:

 

Moderna- 2 Vaccine Stocks That Can Double Your Money- Part1